Imen Ben‐Salha

University College Hospital, University College London

Papers

2

Total Citations

50

H-Index

2

About

Imen Ben‑Salha is a clinical researcher whose work focuses on improving surgical and diagnostic outcomes in prostate cancer, particularly through the integration of pathology and imaging. Her most notable contribution is as a lead author on the NeuroSAFE PROOF feasibility randomized controlled trial, which evaluated the use of intraoperative frozen section analysis during robot‑assisted radical prostatectomy. This study, cited 46 times, demonstrated high histopathological concordance between frozen and final sections, supporting the feasibility of nerve‑sparing surgery guided by real‑time pathology to preserve erectile function without compromising oncological control. Ben‑Salha also developed the PEOPLE tissue collection pathway, which uses magnetic resonance imaging data to precisely target tumor and benign tissue in fresh prostatectomy specimens. This innovation addresses a critical need in prostate cancer research by enabling high‑quality, spatially accurate tissue sampling for translational studies. Her work bridges surgical technique, pathology, and translational science, with direct implications for personalized treatment and biobanking. Ben‑Salha’s contributions are shaping how surgeons and researchers approach prostate cancer management and tissue‑based discovery.

Research Focus

Key Achievements

2
H-Index
2
Papers
50
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
NeuroSAFE frozen section during robot‐assisted radical prostatectomy: peri‐operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial
46 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: University College Hospital, University College London

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago